Your browser doesn't support javascript.
loading
Optimal Time Point for Evaluation of Response to Pembrolizumab Treatment in Japanese Patients With Metastatic Urothelial Carcinoma.
Inamoto, Teruo; Sato, Ryo; Matsushita, Yuto; Uchimoto, Taizo; Nakamura, K O; Komura, Kazumasa; Nishimura, Kazuki; Yano, Yusuke; Nishio, Kyosuke; Kinoshita, Shoko; Fukushima, Tatsuo; Matsunaga, Tomohisa; Nakamori, Keita; Tsutsumi, Takeshi; Tsujino, Takuya; Uehara, Hirofumi; Takahara, Kiyoshi; Miyake, Hideaki; Azuma, Haruhito.
Affiliation
  • Inamoto T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Sato R; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Matsushita Y; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Uchimoto T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Nakamura KO; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Komura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Nishimura K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Yano Y; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Nishio K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Kinoshita S; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Fukushima T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Matsunaga T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Nakamori K; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Tsutsumi T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Tsujino T; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Uehara H; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
  • Takahara K; Department of Urology, Fujita-Health University School of Medicine, Toyoake, Japan.
  • Miyake H; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Azuma H; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Cancer Diagn Progn ; 3(3): 370-376, 2023.
Article in En | MEDLINE | ID: mdl-37168961